+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Progesterone Receptor Modulator Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6124790
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The progesterone receptor modulator market is undergoing significant transformation, propelled by advancements in molecular biology, targeted drug development, and growing demand for innovative therapies in women’s health. Market participants are balancing demand for precise hormone control across gynecological, fertility, and oncology applications with evolving regulatory and supply chain considerations.

Market Snapshot: Progesterone Receptor Modulator Industry

Spurred by a deeper understanding of hormone pathways, the global progesterone receptor modulator market is experiencing accelerated growth. Key drivers include unmet clinical needs in conditions such as endometriosis, uterine fibroids, hormone-responsive cancers, and rising emphasis on individualized therapy. Both incumbents and new entrants are highly active, expanding pipelines and bringing novel selective modulators to market.

Scope & Segmentation

  • Indications: Breast cancer, endometriosis, fertility treatment, uterine fibroids.
  • Product Types: Agonists, antagonists, selective modulators.
  • Distribution Channels: Hospital pharmacy, online pharmacy (business to business, business to consumer), retail pharmacy.
  • Dosage Forms: Capsules (hard, soft gelatin), injectables (intramuscular, intravenous), oral tablets (extended release, immediate release), topical gels.
  • Route of Administration: Oral, parenteral, topical.
  • End Users: Home care settings, hospitals (government, private), specialty clinics.
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, and more).
  • Leading Companies Covered: HRA Pharma SAS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Novartis AG, Bayer AG.

Key Takeaways for Senior Decision-Makers

  • The landscape is shifting towards selective modulators that finely control receptor activation in target tissues, reducing systemic side effects and enhancing treatment precision.
  • Precision medicine and companion diagnostics are improving clinical trial outcomes by enabling patient stratification based on receptor expression and genetic markers.
  • Collaborative research and development partnerships—including between biopharma, academic centers, and contract organizations—are reducing early-stage attrition and bringing robust candidates to late-stage development.
  • The integration of digital health tools is driving efficiency, with real-world data collection supporting adaptive trial designs and swift regulatory approvals.
  • Regional adoption varies: North America benefits from strong trial ecosystems and reimbursement models; Western Europe leverages centralized approvals; Asia-Pacific, particularly Japan, China, and India, is accelerating via policy innovation and domestic manufacturing capacity.

Impact of United States Tariff Changes in 2025

Recent U.S. tariff adjustments are raising import duties on key raw materials, resulting in increased manufacturing costs for progesterone receptor modulators. Manufacturers are responding by nearshoring operations, entering long-term domestic supply agreements, and evaluating toll-manufacturing in favorable trade jurisdictions. These supply chain realignments are driving a shift toward vertically integrated models and compelling stronger value communication with payers through outcomes research.

Methodology & Data Sources

This analysis leverages peer-reviewed literature, clinical trial registries, regulatory filings, and patent reviews. Structured interviews with experts across clinical, academic, and payer channels inform market context, while quantitative models validate trends through sales, prescription patterns, and epidemiology. Scenario analysis was applied to assess the effects of policy changes and tariff implementations.

Why This Report Matters

  • Enables executive teams to benchmark strategic plans against competitor innovation pathways and evolving regulatory landscapes.
  • Equips supply chain, medical affairs, and commercial leaders with actionable segmentation and market entry insights tailored to regional and product-specific opportunities.

Conclusion

Senior stakeholders can leverage this resource to anticipate market trends, harness new R&D models, and navigate tariff-driven complexities. Aligning R&D investments, digital engagement, and regional commercialization is key to sustaining long-term market presence.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising clinical trial activity for selective progesterone receptor modulators targeting endometriosis symptoms management
5.2. Emerging oral progesterone receptor modulators gaining regulatory designations for uterine fibroids treatment
5.3. Strategic partnerships between biotech firms and big pharma accelerating PRM pipeline for breast cancer therapies
5.4. Innovative nanoparticle formulation approaches improving bioavailability of progesterone receptor modulators in clinical use
5.5. Integration of pharmacogenomic profiling to personalize PRM therapy for women with hormone-related disorders
5.6. Expanding payer coverage and pricing negotiations influencing access to novel progesterone receptor modulators
5.7. Use of AI-driven drug discovery platforms to identify next-generation selective progesterone receptor modulators
5.8. Market penetration strategies targeting emerging Asian markets for second-generation PRM therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Progesterone Receptor Modulator Market, by Indication
8.1. Introduction
8.2. Breast Cancer
8.3. Endometriosis
8.4. Fertility Treatment
8.5. Uterine Fibroids
9. Progesterone Receptor Modulator Market, by Product Type
9.1. Introduction
9.2. Agonists
9.3. Antagonists
9.4. Selective Modulators
10. Progesterone Receptor Modulator Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Business to Business
10.3.2. Business to Consumer
10.4. Retail Pharmacy
11. Progesterone Receptor Modulator Market, by Dosage Form
11.1. Introduction
11.2. Capsules
11.2.1. Hard Capsules
11.2.2. Soft Gelatin
11.3. Injectables
11.3.1. Intramuscular
11.3.2. Intravenous
11.4. Oral Tablets
11.4.1. Extended Release
11.4.2. Immediate Release
11.5. Topical Gels
12. Progesterone Receptor Modulator Market, by Route of Administration
12.1. Introduction
12.2. Oral
12.3. Parenteral
12.4. Topical
13. Progesterone Receptor Modulator Market, by End User
13.1. Introduction
13.2. Home Care Settings
13.3. Hospitals
13.3.1. Government Hospitals
13.3.2. Private Hospitals
13.4. Specialty Clinics
14. Americas Progesterone Receptor Modulator Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Progesterone Receptor Modulator Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Progesterone Receptor Modulator Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. HRA Pharma SAS
17.3.2. Pfizer Inc.
17.3.3. Teva Pharmaceutical Industries Ltd.
17.3.4. Viatris Inc.
17.3.5. Dr. Reddy's Laboratories Limited
17.3.6. Sun Pharmaceutical Industries Limited
17.3.7. Cipla Limited
17.3.8. Lupin Limited
17.3.9. Novartis AG
17.3.10. Bayer AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PROGESTERONE RECEPTOR MODULATOR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PROGESTERONE RECEPTOR MODULATOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PROGESTERONE RECEPTOR MODULATOR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PROGESTERONE RECEPTOR MODULATOR MARKET: RESEARCHAI
FIGURE 28. PROGESTERONE RECEPTOR MODULATOR MARKET: RESEARCHSTATISTICS
FIGURE 29. PROGESTERONE RECEPTOR MODULATOR MARKET: RESEARCHCONTACTS
FIGURE 30. PROGESTERONE RECEPTOR MODULATOR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PROGESTERONE RECEPTOR MODULATOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY FERTILITY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY FERTILITY TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY AGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY AGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SELECTIVE MODULATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SELECTIVE MODULATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO BUSINESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY BUSINESS TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HARD CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SOFT GELATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SOFT GELATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 150. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 151. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 152. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 153. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 154. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 155. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. CANADA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 282. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 283. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2018-2024 (USD MILLION)
TABLE 284. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY CAPSULES, 2025-2030 (USD MILLION)
TABLE 285. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2018-2024 (USD MILLION)
TABLE 286. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INJECTABLES, 2025-2030 (USD MILLION)
TABLE 287. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ORAL TABLETS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. FRANCE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. FRANCE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. FRANCE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. FRANCE PROGESTERONE RECEPTOR MODULATOR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE PROGES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Progesterone Receptor Modulator market report include:
  • HRA Pharma SAS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Dr. Reddy's Laboratories Limited
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Lupin Limited
  • Novartis AG
  • Bayer AG